EE359 Real-World Utilization, Treatment Frequency, and Bleeding Outcomes on Damoctocog Alfa Pegol in Haemophilia A Care: Insights From a German Cohort Within the CHESS II Study
Abstract
Authors
W Zhang E Ferri Grazzi J O'Hara T Burke